BioCentury
ARTICLE | Clinical News

Lytixar: Phase I/IIa data

June 6, 2011 7:00 AM UTC

A placebo-controlled, Hungarian Phase I/IIa trial showed that Lytixar was well tolerated, with negligible systemic uptake. ...